Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy

NCT07670442 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Assistance Publique - Hôpitaux de Paris